NO773296L - Fremgangsmaate ved fremstilling av farmakologisk aktive forbindelser - Google Patents
Fremgangsmaate ved fremstilling av farmakologisk aktive forbindelserInfo
- Publication number
- NO773296L NO773296L NO773296A NO773296A NO773296L NO 773296 L NO773296 L NO 773296L NO 773296 A NO773296 A NO 773296A NO 773296 A NO773296 A NO 773296A NO 773296 L NO773296 L NO 773296L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- mol
- bis
- thiazole
- dihydroimidazo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 58
- 238000000034 method Methods 0.000 title claims description 41
- 238000002360 preparation method Methods 0.000 title claims description 10
- 230000000144 pharmacologic effect Effects 0.000 title description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 63
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 60
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 44
- -1 3,4-methylenedioxy Chemical group 0.000 claims description 26
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 22
- REGFWZVTTFGQOJ-UHFFFAOYSA-N 4,5-dihydro-1,3-thiazol-2-amine Chemical compound NC1=NCCS1 REGFWZVTTFGQOJ-UHFFFAOYSA-N 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 15
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 14
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 14
- 229910052794 bromium Inorganic materials 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 125000003282 alkyl amino group Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 230000029936 alkylation Effects 0.000 claims description 6
- 238000005804 alkylation reaction Methods 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 claims description 4
- 125000004423 acyloxy group Chemical group 0.000 claims description 4
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 125000005336 allyloxy group Chemical group 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 230000010933 acylation Effects 0.000 claims description 2
- 238000005917 acylation reaction Methods 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000003495 polar organic solvent Substances 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 90
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 69
- 239000000243 solution Substances 0.000 description 67
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 45
- 239000000203 mixture Substances 0.000 description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 238000002844 melting Methods 0.000 description 31
- 230000008018 melting Effects 0.000 description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- 238000010992 reflux Methods 0.000 description 28
- 239000002904 solvent Substances 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 22
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 244000028419 Styrax benzoin Species 0.000 description 16
- 235000000126 Styrax benzoin Nutrition 0.000 description 16
- 235000008411 Sumatra benzointree Nutrition 0.000 description 16
- 235000019382 gum benzoic Nutrition 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 15
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 14
- 239000007787 solid Substances 0.000 description 13
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 12
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 12
- LVUHRKYFLHPLAF-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N2CCSC2=N1 LVUHRKYFLHPLAF-UHFFFAOYSA-N 0.000 description 11
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 11
- 235000019341 magnesium sulphate Nutrition 0.000 description 11
- 229910000029 sodium carbonate Inorganic materials 0.000 description 11
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 10
- 229960002130 benzoin Drugs 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 230000002456 anti-arthritic effect Effects 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- OTKCEEWUXHVZQI-UHFFFAOYSA-N 1,2-diphenylethanone Chemical class C=1C=CC=CC=1C(=O)CC1=CC=CC=C1 OTKCEEWUXHVZQI-UHFFFAOYSA-N 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 7
- 206010003246 arthritis Diseases 0.000 description 7
- 239000005457 ice water Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 238000010533 azeotropic distillation Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 5
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000003610 charcoal Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000012258 stirred mixture Substances 0.000 description 4
- BJCIJTYQFAOPCE-UHFFFAOYSA-N 2-bromo-1,2-bis(4-methoxyphenyl)ethanone Chemical compound C1=CC(OC)=CC=C1C(Br)C(=O)C1=CC=C(OC)C=C1 BJCIJTYQFAOPCE-UHFFFAOYSA-N 0.000 description 3
- OTXSGXZSACCJRN-UHFFFAOYSA-N 4-[5-(4-hydroxyphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]phenol;hydrobromide Chemical compound Br.C1=CC(O)=CC=C1C1=C(C=2C=CC(O)=CC=2)N2CCSC2=N1 OTXSGXZSACCJRN-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010036030 Polyarthritis Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 230000004957 immunoregulator effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- AEWSTPHDURNJOY-UHFFFAOYSA-N n-[4-[5-(4-acetamidophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1=C(C=2C=CC(NC(C)=O)=CC=2)N2CCSC2=N1 AEWSTPHDURNJOY-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000008177 pharmaceutical agent Substances 0.000 description 3
- 208000030428 polyarticular arthritis Diseases 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical compound SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 2
- BOFZOFCSIFMCEB-UHFFFAOYSA-N 1-(2-bromophenyl)-2-phenylethanone Chemical compound BrC1=CC=CC=C1C(=O)CC1=CC=CC=C1 BOFZOFCSIFMCEB-UHFFFAOYSA-N 0.000 description 2
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- OQBQGLWXHMQGEN-UHFFFAOYSA-N 4,5-bis(1,3-benzodioxol-5-yl)-1,3-dihydroimidazole-2-thione Chemical compound C1=C2OCOC2=CC(C=2NC(NC=2C=2C=C3OCOC3=CC=2)=S)=C1 OQBQGLWXHMQGEN-UHFFFAOYSA-N 0.000 description 2
- PFCBNIAUGCRXPR-UHFFFAOYSA-N 4,5-bis(4-methylsulfanylphenyl)-1,3-dihydroimidazole-2-thione Chemical compound C1=CC(SC)=CC=C1C1=C(C=2C=CC(SC)=CC=2)NC(S)=N1 PFCBNIAUGCRXPR-UHFFFAOYSA-N 0.000 description 2
- DCYYVPJKGOTQBP-UHFFFAOYSA-N 4-[5-(4-aminophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]aniline Chemical compound C1=CC(N)=CC=C1C1=C(C=2C=CC(N)=CC=2)N2CCSC2=N1 DCYYVPJKGOTQBP-UHFFFAOYSA-N 0.000 description 2
- LPJBOYDHVYYELT-UHFFFAOYSA-N 5,6-diphenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical class S1CCN2C1=NC(C=1C=CC=CC=1)=C2C1=CC=CC=C1 LPJBOYDHVYYELT-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000009386 Experimental Arthritis Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000024932 T cell mediated immunity Effects 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229960001614 levamisole Drugs 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- QTYQKWQRBTWGBA-UHFFFAOYSA-N n-[4-[5-(4-acetamidophenyl)-2-sulfanylidene-1,3-dihydroimidazol-4-yl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1=C(C=2C=CC(NC(C)=O)=CC=2)NC(S)=N1 QTYQKWQRBTWGBA-UHFFFAOYSA-N 0.000 description 2
- SUGCKVLPUYBGOU-UHFFFAOYSA-N n-[4-[5-[4-[acetyl(ethyl)amino]phenyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-n-ethylacetamide Chemical compound C1=CC(N(C(C)=O)CC)=CC=C1C1=C(C=2C=CC(=CC=2)N(CC)C(C)=O)N2CCSC2=N1 SUGCKVLPUYBGOU-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- SICBLYCPRWNHHP-UHFFFAOYSA-N 1,2-bis(4-methoxyphenyl)ethanone Chemical compound C1=CC(OC)=CC=C1CC(=O)C1=CC=C(OC)C=C1 SICBLYCPRWNHHP-UHFFFAOYSA-N 0.000 description 1
- KBBJRXQPTGJZMR-UHFFFAOYSA-N 1-(2-methylphenyl)-2-(3-methylphenyl)ethanone Chemical compound CC1=CC=CC(CC(=O)C=2C(=CC=CC=2)C)=C1 KBBJRXQPTGJZMR-UHFFFAOYSA-N 0.000 description 1
- USPQTMWYGMQUTH-UHFFFAOYSA-N 1-(3-methylphenyl)-2-(4-methylphenyl)ethanone Chemical compound C1=CC(C)=CC=C1CC(=O)C1=CC=CC(C)=C1 USPQTMWYGMQUTH-UHFFFAOYSA-N 0.000 description 1
- CVONNCNINLEUKH-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-methoxyphenyl)ethanone Chemical compound C1=CC(OC)=CC=C1CC(=O)C1=CC=C(Cl)C=C1 CVONNCNINLEUKH-UHFFFAOYSA-N 0.000 description 1
- RTMMSCJWQYWMNK-UHFFFAOYSA-N 2,2,2-trifluoroethyl trifluoromethanesulfonate Chemical compound FC(F)(F)COS(=O)(=O)C(F)(F)F RTMMSCJWQYWMNK-UHFFFAOYSA-N 0.000 description 1
- PGZVFRAEAAXREB-UHFFFAOYSA-N 2,2-dimethylpropanoyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(=O)C(C)(C)C PGZVFRAEAAXREB-UHFFFAOYSA-N 0.000 description 1
- LCCQUAVRRQQTLG-UHFFFAOYSA-N 2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical class C1=CN=C2SCCN21 LCCQUAVRRQQTLG-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- VMEPFMQBGKXQKU-UHFFFAOYSA-N 2-(2-chlorophenyl)-1-(4-chlorophenyl)ethanone Chemical compound C1=CC(Cl)=CC=C1C(=O)CC1=CC=CC=C1Cl VMEPFMQBGKXQKU-UHFFFAOYSA-N 0.000 description 1
- BPWUXCSHXJVUKT-UHFFFAOYSA-N 2-bromo-1-(3,4-dimethoxyphenyl)-2-phenylethanone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)C(Br)C1=CC=CC=C1 BPWUXCSHXJVUKT-UHFFFAOYSA-N 0.000 description 1
- CKZXADVHFFKWKQ-UHFFFAOYSA-N 2-hydroxy-1,2-bis(2-methoxyphenyl)ethanone Chemical compound COC1=CC=CC=C1C(O)C(=O)C1=CC=CC=C1OC CKZXADVHFFKWKQ-UHFFFAOYSA-N 0.000 description 1
- CZOPVKGENSIFOT-UHFFFAOYSA-N 2-hydroxy-1,2-bis(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(C(O)C(=O)C=2C=C(OC)C=CC=2)=C1 CZOPVKGENSIFOT-UHFFFAOYSA-N 0.000 description 1
- LRRQSCPPOIUNGX-UHFFFAOYSA-N 2-hydroxy-1,2-bis(4-methoxyphenyl)ethanone Chemical compound C1=CC(OC)=CC=C1C(O)C(=O)C1=CC=C(OC)C=C1 LRRQSCPPOIUNGX-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DFGWUTSLOZLPQK-UHFFFAOYSA-N 4,5-bis(3-fluorophenyl)-1,3-dihydroimidazole-2-thione Chemical compound FC1=CC=CC(C2=C(NC(S)=N2)C=2C=C(F)C=CC=2)=C1 DFGWUTSLOZLPQK-UHFFFAOYSA-N 0.000 description 1
- GIDFBQLMHAXKGK-UHFFFAOYSA-N 4,5-bis(3-methylphenyl)-1,3-dihydroimidazole-2-thione Chemical compound CC1=CC=CC(C2=C(NC(S)=N2)C=2C=C(C)C=CC=2)=C1 GIDFBQLMHAXKGK-UHFFFAOYSA-N 0.000 description 1
- ZNJAXNXHXXYAAS-UHFFFAOYSA-N 4,5-bis(4-methylsulfinylphenyl)-1,3-dihydroimidazole-2-thione Chemical compound C1=CC(S(=O)C)=CC=C1C1=C(C=2C=CC(=CC=2)S(C)=O)NC(S)=N1 ZNJAXNXHXXYAAS-UHFFFAOYSA-N 0.000 description 1
- IPVFCRUKTBYITA-UHFFFAOYSA-N 4,5-bis[(4-methoxyphenyl)methyl]-1,3-dihydroimidazole-2-thione Chemical compound C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)NC(S)=N1 IPVFCRUKTBYITA-UHFFFAOYSA-N 0.000 description 1
- GMTAWLUJHGIUPU-UHFFFAOYSA-N 4,5-diphenyl-1,3-dihydroimidazole-2-thione Chemical compound N1C(S)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 GMTAWLUJHGIUPU-UHFFFAOYSA-N 0.000 description 1
- VZGITQAWSRBJPP-UHFFFAOYSA-N 4-(2-chloroethyl)-1,2-dimethoxybenzene Chemical compound COC1=CC=C(CCCl)C=C1OC VZGITQAWSRBJPP-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 description 1
- VNROFLPIJHQDLT-UHFFFAOYSA-N 4-[5-(4-hydroxyphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=C(C=2C=CC(O)=CC=2)N2CCSC2=N1 VNROFLPIJHQDLT-UHFFFAOYSA-N 0.000 description 1
- NRPFNQUDKRYCNX-UHFFFAOYSA-N 4-methoxyphenylacetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1 NRPFNQUDKRYCNX-UHFFFAOYSA-N 0.000 description 1
- CTQDSNDDBTXXJO-UHFFFAOYSA-N 5,6-bis(1,3-benzodioxol-5-yl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=C2OCOC2=CC(C=2N=C3N(C=2C=2C=C4OCOC4=CC=2)CCS3)=C1 CTQDSNDDBTXXJO-UHFFFAOYSA-N 0.000 description 1
- FQTJNTJIPDUVIM-UHFFFAOYSA-N 5,6-bis(1,3-benzodioxol-5-yl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=C2OCOC2=CC(C=2N3CCSC3=NC=2C2=CC=C3OCOC3=C2)=C1 FQTJNTJIPDUVIM-UHFFFAOYSA-N 0.000 description 1
- IGIDEFPXZDXRJN-UHFFFAOYSA-N 5,6-bis(2-chlorophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound ClC1=CC=CC=C1C1=C(C=2C(=CC=CC=2)Cl)N2CCSC2=N1 IGIDEFPXZDXRJN-UHFFFAOYSA-N 0.000 description 1
- NTSYUYKBZMZOFL-UHFFFAOYSA-N 5,6-bis(3-fluorophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound FC1=CC=CC(C2=C(N3CCSC3=N2)C=2C=C(F)C=CC=2)=C1 NTSYUYKBZMZOFL-UHFFFAOYSA-N 0.000 description 1
- LWWSYUQAIUOENF-UHFFFAOYSA-N 5,6-bis(3-methylphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound CC1=CC=CC(C2=C(N3CCSC3=N2)C=2C=C(C)C=CC=2)=C1 LWWSYUQAIUOENF-UHFFFAOYSA-N 0.000 description 1
- WHMACQCATLASAA-UHFFFAOYSA-N 5,6-bis(4-bromophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(Br)=CC=C1C1=C(C=2C=CC(Br)=CC=2)N2CCSC2=N1 WHMACQCATLASAA-UHFFFAOYSA-N 0.000 description 1
- XAIZXQWCIZIPJW-UHFFFAOYSA-N 5,6-bis(4-butoxyphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C=CC(OCCCC)=CC=2)N2CCSC2=N1 XAIZXQWCIZIPJW-UHFFFAOYSA-N 0.000 description 1
- ZZMHJXQBTKLHNJ-UHFFFAOYSA-N 5,6-bis(4-chlorophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(Cl)=CC=C1C1=C(C=2C=CC(Cl)=CC=2)N2CCSC2=N1 ZZMHJXQBTKLHNJ-UHFFFAOYSA-N 0.000 description 1
- XQHBNRKHFFASMS-UHFFFAOYSA-N 5,6-bis(4-ethoxyphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C=CC(OCC)=CC=2)N2CCSC2=N1 XQHBNRKHFFASMS-UHFFFAOYSA-N 0.000 description 1
- FUVLTSLHPXPUCI-UHFFFAOYSA-N 5,6-bis(4-ethylphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C=CC(CC)=CC=2)N2CCSC2=N1 FUVLTSLHPXPUCI-UHFFFAOYSA-N 0.000 description 1
- BFXXHOVXBQRTRY-UHFFFAOYSA-N 5,6-bis(4-fluorophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(F)=CC=C1C1=C(C=2C=CC(F)=CC=2)N2CCSC2=N1 BFXXHOVXBQRTRY-UHFFFAOYSA-N 0.000 description 1
- NATNMXOIFWIQQI-UHFFFAOYSA-N 5,6-bis(4-fluorophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1C1=C(C=2C=CC(F)=CC=2)N2CCSC2=N1 NATNMXOIFWIQQI-UHFFFAOYSA-N 0.000 description 1
- LWDBOMIJQKTTHF-UHFFFAOYSA-N 5,6-bis(4-methylphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=CC(C)=CC=C1C1=C(C=2C=CC(C)=CC=2)N2CCSC2=N1 LWDBOMIJQKTTHF-UHFFFAOYSA-N 0.000 description 1
- NUAVOZQGBFSTAS-UHFFFAOYSA-N 5,6-bis(4-methylsulfanylphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(SC)=CC=C1C1=C(C=2C=CC(SC)=CC=2)N2CCSC2=N1 NUAVOZQGBFSTAS-UHFFFAOYSA-N 0.000 description 1
- WZSAIAQVSBCMIK-UHFFFAOYSA-N 5,6-bis(4-methylsulfanylphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=CC(SC)=CC=C1C1=C(C=2C=CC(SC)=CC=2)N2CCSC2=N1 WZSAIAQVSBCMIK-UHFFFAOYSA-N 0.000 description 1
- PXRNNWLIYCZZBU-UHFFFAOYSA-N 5,6-bis[(2-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound COC1=CC=CC=C1CC1=C(CC=2C(=CC=CC=2)OC)N2CCSC2=N1 PXRNNWLIYCZZBU-UHFFFAOYSA-N 0.000 description 1
- IXDWXOWYGCZURS-UHFFFAOYSA-N 5,6-bis[(3-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound COC1=CC=CC(CC2=C(N3CCSC3=N2)CC=2C=C(OC)C=CC=2)=C1 IXDWXOWYGCZURS-UHFFFAOYSA-N 0.000 description 1
- QFVJUHXOMWBSNN-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole 1,1-dioxide Chemical compound C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N(CCS2(=O)=O)C2=N1 QFVJUHXOMWBSNN-UHFFFAOYSA-N 0.000 description 1
- JULVVOVLVOQQFZ-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole 1-oxide Chemical compound C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N(CCS2=O)C2=N1 JULVVOVLVOQQFZ-UHFFFAOYSA-N 0.000 description 1
- ZPRZUYMIIDXZKL-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N2CCSC2=N1 ZPRZUYMIIDXZKL-UHFFFAOYSA-N 0.000 description 1
- GQKDAXDQFTXFFG-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N2CCSC2=N1 GQKDAXDQFTXFFG-UHFFFAOYSA-N 0.000 description 1
- QEROKBXHPBBFIH-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole;phosphoric acid Chemical compound OP(O)(O)=O.C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N2CCSC2=N1 QEROKBXHPBBFIH-UHFFFAOYSA-N 0.000 description 1
- RDFBOTZUEYAZSS-UHFFFAOYSA-N 5,6-bis[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC(OC)=CC=C1CC1=C(CC=2C=CC(OC)=CC=2)N2CCSC2=N1 RDFBOTZUEYAZSS-UHFFFAOYSA-N 0.000 description 1
- ZORHYEMLDXEDGU-UHFFFAOYSA-N 5,6-bis[4-(2,2,2-trifluoroethoxy)phenyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OCC(F)(F)F)=CC=C1C1=C(C=2C=CC(OCC(F)(F)F)=CC=2)N2CCSC2=N1 ZORHYEMLDXEDGU-UHFFFAOYSA-N 0.000 description 1
- VHJAWBATOWNDEA-UHFFFAOYSA-N 5,6-bis[4-(trifluoromethyl)phenyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=CC(C(F)(F)F)=CC=C1C1=C(C=2C=CC(=CC=2)C(F)(F)F)N2CCSC2=N1 VHJAWBATOWNDEA-UHFFFAOYSA-N 0.000 description 1
- PZQUPRBQIGPICX-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C=CC=CC=2)N=C2N1CCS2 PZQUPRBQIGPICX-UHFFFAOYSA-N 0.000 description 1
- LCONSLVGGVYBSC-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=C(OC)C(OC)=CC=C1C1=C(C=2C=CC=CC=2)N=C2N1CCS2 LCONSLVGGVYBSC-UHFFFAOYSA-N 0.000 description 1
- CZLHRKGIGUIYSE-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OC)=CC=C1CC1=C(C=2C=CC=CC=2)N=C2N1CCS2 CZLHRKGIGUIYSE-UHFFFAOYSA-N 0.000 description 1
- JAFJLMGHFIRCKS-UHFFFAOYSA-N 6-(3,4-dimethoxyphenyl)-5-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrobromide Chemical compound Br.C1=C(OC)C(OC)=CC=C1C1=C(C=2C=CC=CC=2)N2CCSC2=N1 JAFJLMGHFIRCKS-UHFFFAOYSA-N 0.000 description 1
- KSBNVLXNCBPSHB-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-[(4-methoxyphenyl)methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OC)=CC=C1CC1=C(C=2C=CC(Cl)=CC=2)N=C2N1CCS2 KSBNVLXNCBPSHB-UHFFFAOYSA-N 0.000 description 1
- YIGYSJNVGSYICI-UHFFFAOYSA-N 6-[(4-methoxyphenyl)methyl]-5-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole Chemical compound C1=CC(OC)=CC=C1CC1=C(C=2C=CC=CC=2)N2CCSC2=N1 YIGYSJNVGSYICI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
- 241001591774 Illice Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- NRRNJQVXSZAZOC-UHFFFAOYSA-N [4-[5-(4-acetyloxyphenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]phenyl] acetate Chemical compound C1=CC(OC(=O)C)=CC=C1C1=C(C=2C=CC(OC(C)=O)=CC=2)N2CCSC2=N1 NRRNJQVXSZAZOC-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- AIXXFHBAIYTUNH-UHFFFAOYSA-M aluminum butanoate oxygen(2-) Chemical compound [O--].[Al+3].CCCC([O-])=O AIXXFHBAIYTUNH-UHFFFAOYSA-M 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 150000008359 benzonitriles Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- YKGMKSIHIVVYKY-UHFFFAOYSA-N dabrafenib mesylate Chemical compound CS(O)(=O)=O.S1C(C(C)(C)C)=NC(C=2C(=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C=CC=2)F)=C1C1=CC=NC(N)=N1 YKGMKSIHIVVYKY-UHFFFAOYSA-N 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940015045 gold sodium thiomalate Drugs 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- SCEZYJKGDJPHQO-UHFFFAOYSA-M magnesium;methanidylbenzene;chloride Chemical class [Mg+2].[Cl-].[CH2-]C1=CC=CC=C1 SCEZYJKGDJPHQO-UHFFFAOYSA-M 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- DIQHKLDRKRODCS-UHFFFAOYSA-N n-[4-[5-[4-(2,2-dimethylpropanoylamino)phenyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2,2-dimethylpropanamide Chemical compound C1=CC(NC(=O)C(C)(C)C)=CC=C1C1=C(C=2C=CC(NC(=O)C(C)(C)C)=CC=2)N2CCSC2=N1 DIQHKLDRKRODCS-UHFFFAOYSA-N 0.000 description 1
- YWIRVNGDMQBLKW-UHFFFAOYSA-N n-ethyl-4-[5-[4-(ethylamino)phenyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl]aniline Chemical compound C1=CC(NCC)=CC=C1C1=C(C=2C=CC(NCC)=CC=2)N2CCSC2=N1 YWIRVNGDMQBLKW-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- AGHLUVOCTHWMJV-UHFFFAOYSA-J sodium;gold(3+);2-sulfanylbutanedioate Chemical compound [Na+].[Au+3].[O-]C(=O)CC(S)C([O-])=O.[O-]C(=O)CC(S)C([O-])=O AGHLUVOCTHWMJV-UHFFFAOYSA-J 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72718476A | 1976-09-27 | 1976-09-27 | |
| US05/825,612 US4263311A (en) | 1976-09-27 | 1977-08-18 | 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO773296L true NO773296L (no) | 1978-03-29 |
Family
ID=27111468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO773296A NO773296L (no) | 1976-09-27 | 1977-09-26 | Fremgangsmaate ved fremstilling av farmakologisk aktive forbindelser |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4263311A (ja) |
| JP (1) | JPS5340797A (ja) |
| AU (1) | AU2882977A (ja) |
| DD (1) | DD132587A5 (ja) |
| DE (1) | DE2742725A1 (ja) |
| DK (1) | DK406077A (ja) |
| ES (1) | ES462445A1 (ja) |
| FI (1) | FI772829A (ja) |
| FR (1) | FR2365572A1 (ja) |
| GR (1) | GR63698B (ja) |
| IT (1) | IT1143693B (ja) |
| LU (1) | LU78172A1 (ja) |
| NL (1) | NL7710528A (ja) |
| NO (1) | NO773296L (ja) |
| NZ (1) | NZ185169A (ja) |
| PL (1) | PL201082A1 (ja) |
| PT (1) | PT67046B (ja) |
| SE (1) | SE7710762L (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU77703A1 (de) * | 1977-07-07 | 1979-03-26 | Ciba Geigy Ag | Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen |
| US4175127A (en) * | 1978-09-27 | 1979-11-20 | Smithkline Corporation | Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles |
| PL221188A1 (ja) * | 1979-01-05 | 1980-12-01 | Ciba Geigy Ag | |
| JPS5687553A (en) * | 1979-11-23 | 1981-07-16 | Sandoz Ag | Improved alkylation |
| US4444770A (en) * | 1980-05-29 | 1984-04-24 | Bayer Aktiengesellschaft | New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use |
| JPS59172328A (ja) * | 1983-03-16 | 1984-09-29 | Hitachi Ltd | スラリ−連続圧送装置 |
| US5145858A (en) * | 1985-12-12 | 1992-09-08 | Smithkline Beecham Corp. | Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| ZW24186A1 (en) * | 1985-12-12 | 1987-07-08 | Smithkline Beckman Corp | Inhibition of the 5-lipoxygenase pathway |
| US5134150A (en) * | 1985-12-12 | 1992-07-28 | Smithkline Beecham Corporation | Inhibition of the 5-lipoxygenase pathway |
| US5002941A (en) * | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| US4751310A (en) * | 1985-12-12 | 1988-06-14 | Smithkline Beckman Corporation | Inhibition of the 5-lipoxygenase pathway |
| US4719218A (en) * | 1985-12-12 | 1988-01-12 | Smithkline Beckman Corporation | Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor |
| US4794114A (en) * | 1986-08-19 | 1988-12-27 | Smithkline Beckman Corporation | Inhibition of interleukin-1 production by monocytes and/or macrophages |
| JP2816224B2 (ja) * | 1990-03-16 | 1998-10-27 | 株式会社日立製作所 | 多筒式水ピストン型流体圧送装置 |
| US5698711A (en) | 1991-01-28 | 1997-12-16 | Rhone-Poulenc Rorer Limited | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group |
| US5935978A (en) * | 1991-01-28 | 1999-08-10 | Rhone-Poulenc Rorer Limited | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group |
| GB9311281D0 (en) * | 1993-06-01 | 1993-07-21 | Rhone Poulenc Rorer Ltd | Novel composition of matter |
| US5679696A (en) * | 1992-07-28 | 1997-10-21 | Rhone-Poulenc Rorer Limited | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group |
| US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| CN109748831A (zh) * | 2018-12-17 | 2019-05-14 | 南通正达农化有限公司 | 一种三氟甲磺酸三氟乙酯的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2969369A (en) * | 1959-10-23 | 1961-01-24 | Searle & Co | Derivatives of 3-phenyl-5, 6-dihydroimidazo-[2. 1-b] thiazoles |
| NL129432C (ja) * | 1964-02-29 | |||
| NL131034C (ja) * | 1964-05-11 | |||
| US4059588A (en) * | 1965-07-19 | 1977-11-22 | Ici Australia Limited | Process for preparing 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole |
| US3455924A (en) * | 1967-02-08 | 1969-07-15 | Upjohn Co | Dianisylimidazoles |
| NL164285C (nl) * | 1968-01-09 | 1980-12-15 | Rhone Poulenc Sa | Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat. |
| US3732215A (en) * | 1971-02-08 | 1973-05-08 | Squibb & Sons Inc | Imidazole derivatives |
| HU169255B (ja) * | 1973-06-20 | 1976-10-28 | ||
| US3895021A (en) * | 1973-09-04 | 1975-07-15 | Smithkline Corp | N-heterocyclic pulvinic acid amides |
| FR2271213A1 (en) * | 1974-05-16 | 1975-12-12 | Aries Robert | Tetramisole anthelmintics prepn. - by reaction of ethylene thiourea with vinyl halide and base |
| GB1541321A (en) * | 1976-03-10 | 1979-02-28 | Metabio | 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation |
-
1977
- 1977-08-18 US US05/825,612 patent/US4263311A/en not_active Expired - Lifetime
- 1977-09-12 NZ NZ185169A patent/NZ185169A/xx unknown
- 1977-09-13 DK DK406077A patent/DK406077A/da unknown
- 1977-09-15 AU AU28829/77A patent/AU2882977A/en active Pending
- 1977-09-17 ES ES462445A patent/ES462445A1/es not_active Expired
- 1977-09-19 PT PT67046A patent/PT67046B/pt unknown
- 1977-09-22 FR FR7728627A patent/FR2365572A1/fr active Granted
- 1977-09-22 DE DE19772742725 patent/DE2742725A1/de not_active Withdrawn
- 1977-09-23 LU LU78172A patent/LU78172A1/xx unknown
- 1977-09-23 IT IT27901/77A patent/IT1143693B/it active
- 1977-09-26 GR GR54426A patent/GR63698B/el unknown
- 1977-09-26 SE SE7710762A patent/SE7710762L/xx unknown
- 1977-09-26 NO NO773296A patent/NO773296L/no unknown
- 1977-09-26 FI FI772829A patent/FI772829A/fi not_active Application Discontinuation
- 1977-09-27 DD DD7700201224A patent/DD132587A5/xx unknown
- 1977-09-27 JP JP11654177A patent/JPS5340797A/ja active Granted
- 1977-09-27 NL NL7710528A patent/NL7710528A/xx not_active Application Discontinuation
- 1977-09-27 PL PL20108277A patent/PL201082A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR63698B (en) | 1979-11-30 |
| DE2742725A1 (de) | 1978-03-30 |
| DD132587A5 (de) | 1978-10-11 |
| NZ185169A (en) | 1979-10-25 |
| JPS5340797A (en) | 1978-04-13 |
| PT67046B (en) | 1979-02-16 |
| FR2365572A1 (fr) | 1978-04-21 |
| LU78172A1 (ja) | 1978-01-24 |
| FI772829A (fi) | 1978-03-28 |
| DK406077A (da) | 1978-03-28 |
| PT67046A (en) | 1977-10-01 |
| NL7710528A (nl) | 1978-03-29 |
| JPS6247875B2 (ja) | 1987-10-09 |
| US4263311A (en) | 1981-04-21 |
| SE7710762L (sv) | 1978-03-28 |
| FR2365572B1 (ja) | 1980-11-28 |
| PL201082A1 (pl) | 1978-12-18 |
| AU2882977A (en) | 1979-03-22 |
| IT1143693B (it) | 1986-10-22 |
| ES462445A1 (es) | 1978-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO773296L (no) | Fremgangsmaate ved fremstilling av farmakologisk aktive forbindelser | |
| CA1128947A (en) | 5-(4-pyridyl)-6-(4-fluorophenyl)-2,3- dihydroimidazo¬2,1-b|thiazole | |
| US4110337A (en) | Triazolobenzodiazepines | |
| EP0050326B1 (en) | Benzo(b)thiophenes | |
| JPH0314315B2 (ja) | ||
| JPH0146514B2 (ja) | ||
| KR900005836B1 (ko) | 1,2,4-트리아조로[4,3-c]피리미딘 | |
| EP0120558B1 (en) | Antihypertensive n-piperazinylalkanoylanilides | |
| US4153706A (en) | 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles | |
| EP0147915B1 (en) | New azulene derivatives useful as anti-ulcerative and anti-flammatory agents | |
| US4623648A (en) | 1-azaxanthone for use as therapeutic agent as an antipyretic, analgesic, anti-inflammatory and bronchodilator | |
| Faull et al. | Some reactions of ethyl 2-anilino-4-oxo-4, 5-dihydrothiophen-3-carboxylate | |
| DK156222B (da) | Analogifremgangsmaade til fremstilling af substituerede thiazolooe3,2-aaapyrimidiner eller salte eller isomere eller isomerblandinger heraf | |
| GB2047698A (en) | 6-substituted pyranone compounds and their use as pharmaceuticals | |
| US3886161A (en) | 2-Piperazino-3-cyano-5-phenyl-pyridines | |
| US4496568A (en) | Antiinflammatory thieno [2,3-c]pyridine derivatives | |
| US3709888A (en) | Aryl-substituted-pyrido(2,3-d)pyrimidin-2-ones | |
| KR920000271B1 (ko) | 1,2,4-트리아조로[1,5-c] 피리미딘 및 이의 제조방법 | |
| US4625028A (en) | 6-aryluracils and selected novel intermediates used in the preparation thereof | |
| US4031103A (en) | 1,8-Naphthyridine compounds | |
| CA1230123A (en) | 3-alkyl-8-chloro-5,6-dihydrofuro-¬3,2-f|-1,2- benzisoxazole-6-carboxylic acids | |
| US3826839A (en) | Anti-arthritic compositions comprising ester derivatives of pulvinic acid and methods of producing anti-arthritic activity | |
| CA1051891A (en) | Triazolocycloalkylthiadiazine derivatives | |
| US4521599A (en) | Process for the preparation of 1,3-oxazine-4-ones | |
| US4495349A (en) | 6-Aryluracils |